Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 1088-1095

  Kalkman, Ed A J ^a   Bilgin, Yavuz M ^a   Haren, Peter van ^a   Suylen, Robert Jan van ^a   Saxena, Pramod R ^a   Schoemaker, Regien G ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

coronary artery tone; coronary reserve; hypertension; hypertrophy; myocardial infarction; rat, heart; resistance arteries; vasodilation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; HEART HYPERTROPHY; HEART INFARCTION; HEART PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HYPERTENSION, RENOVASCULAR; HYPERTROPHY, LEFT VENTRICULAR; MALE; RATS; RATS, WISTAR; VASCULAR RESISTANCE; VASODILATION;

EID: 0030476492     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00166-6     Document Type: Article

References (25)

1. Mueller TM, Marcus ML, Kerber RE, Young JA, Barnes RW, Abboud FM. Effect of renal hypertension and left ventricular hypertrophy on the coronary circulation in dogs. Circ Res. 42:1978;543-549.
2. O'Keefe DD, Hoffman JIE, Cheitlin R, O'Neill MJ, Allard JR, Shapkin E. Coronary blood flow in experimental canine left ventricular hypertrophy. Circ Res. 43:1978;43-51.
3. Tomanek RJ, Wangler RD, Bauer CA. Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats. Hypertension. 7:1985;533-540.
4. Canby CA, Tomanek RJ. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy. Am J Physiol. 257:1989;H1110-H1118.
5. Tomanek RJ, Schalk KA, Marcus ML, Harrison DG. Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. Circ Res. 65:1989;352-359.
6. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 69:1991;107-115.
7. Vatner SF, Hittinger L. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol. 22A:1993;34A-40A.
8. Prewitt RL, Chen IIH, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 243:1982;H243-H251.
9. Karam R, Healy BP, Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation. 81:1990;238-246.
10. Drexler H, Hablawetz E, Lu W, Riede U, Christes A. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation. 86:1992;255-262.
11. Nelissen-Vrancken HJMG, Debets JJM, Snoeckx LHEH, Daemen MJAP, Smits JFM. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation. 93:1996;349-355.
12. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 28:1994;1423-1432.
13. Fishbein MC, MacLean D, Maroko PR. Experimental myocardial infarction in the rat. Qualitative and quantitative changes during pathologic evolution. Am J Pathol. 90:1978;57-70.
14. Pfeffer JM, Pfeffer MA, Mirsky I, Steinberg CR, Braunwald E. Progressive ventricular dilatation and diastolic wall stress in rats with myocardial infarction and failure. Circulation 1982;66(II):66(Abstract).
15. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 72:1985;406-412.
16. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 44:1979;503-512.
17. Schoemaker RG, Debets JJM, Struyker-Boudier HAJ, Smits JFM. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol. 23:1991;187-197.
18. Kalkman EAJ, van Suylen RJ, van Dijk JPM, Saxena PR, Schoemaker RG. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium after coronary artery ligation in the rat. J Mol Cell Cardiol. 27:1995;2483-2494.
19. Saxena PR, Schamhardt HC, Forsyth RP, Loeve J. Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comp Prog Biomed. 12:1980;63-84.
20. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol. 25:1993;563-575.
21. Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 20:1992;772-778.
22. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res. 58:1986;26-37.
23. Olivetti G, Ricci R, Beghi C, Guideri G, Anversa P. Response of the border zone to myocardial infarction in rats. Am J Pathol. 125:1986;476-483.
24. Anversa P, Loud AV, Levicky V, Guideri G. Left ventricular failure induced by myocardial infarction. II. Tissue morphometry . Am J Physiol. 248:1985;H883-H889.
25. Kalkman EAJ, Saxena PR, Schoemaker RG. Sensitivity to ischemia of chronically infarcted rat hearts; effects of long-term captopril treatment. Eur J Pharmacol. 298:1996;121-128.